Assessment of hemostatic risk factors in predicting arterial thrombotic events

被引:96
作者
Feinbloom, D
Bauer, KA
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA USA
关键词
arterial; thrombosis; atherosclerosis; hemostasis; risk factors;
D O I
10.1161/01.ATV.0000181762.31694.da
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arterial thrombosis results from endovascular injury and, to a lesser extent, alterations in hemostatic equilibrium. Although multiple hereditary and acquired hemostatic risk factors have been described in the pathophysiology of venous thrombosis, the degree and type of abnormalities that contribute to arterial thrombosis are less well understood. Endothelial cell injury with the elaboration of proinflammatory mediators stimulates the process of arterial thrombosis. Although this is most often the result of endovascular injury attributable to atherosclerotic disease, other disease states can elicit a similar response as well. Similarly, once thrombosis has been initiated, variations in the activity of coagulation proteins and endogenous anticoagulants, as well as the kinetics of platelet aggregation, may alter the effectiveness of thrombus formation. Epidemiological studies have identified several acquired or inherited states that may result in endothelial damage or altered hemostatic equilibrium, thereby predisposing patients to arterial thrombosis. These include hyperhomocysteinemia, elevated C-reactive protein, antiphospholipid antibodies, elevated fibrinogen, Factor VII, plasminogen activator inhibitor-1 (PAI-1), hereditary thrombophilias, and platelet hyper-reactivity. This review explores our present understanding of these risk factors in the development of arterial thrombotic events. At present, the literature supports a role for hyperhomocysteinemia, elevated C-reactive protein, and elevated fibrinogen as risk factors for arterial thrombosis. Similarly, the literature suggests that lupus anticoagulants and, to a lesser extent, elevated titers of cardiolipin IgG antibodies predispose to arterial vascular events. In certain subsets of patients, including those with concomitant cardiac risk factors, < 55 years of age, and women, hereditary thrombophilias such as carriership of the factor V Leiden and the prothrombin G20210A mutations may confer a higher risk of arterial thrombosis. However, the data on Factor VII, PAI-1, and platelet receptor polymorphisms are contradictory or lacking.
引用
收藏
页码:2043 / 2053
页数:11
相关论文
共 128 条
  • [81] Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants
    Padro, T
    Steins, M
    Li, CX
    Mesters, RM
    Hammel, D
    Scheld, HH
    Kienast, J
    [J]. CARDIOVASCULAR RESEARCH, 1997, 36 (01) : 28 - 36
  • [82] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
    Pearson, TA
    Mensah, GA
    Alexander, RW
    Anderson, JL
    Cannon, RO
    Criqui, M
    Fadl, YY
    Fortmann, SP
    Hong, Y
    Myers, GL
    Rifai, N
    Smith, SC
    Taubert, K
    Tracy, RP
    Vinicor, F
    [J]. CIRCULATION, 2003, 107 (03) : 499 - 511
  • [83] C-reactive protein: a critical update
    Pepys, MB
    Hirschfield, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1805 - 1812
  • [84] Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective
    Price, DT
    Ridker, PM
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) : 895 - 903
  • [85] Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease
    Puisieux, F
    de Groote, P
    Masy, E
    Di Pompeo, C
    Millaire, A
    Bouillanne, O
    Jude, B
    Dewailly, P
    Ducloux, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (08) : 635 - 641
  • [86] Lupus anticoagulant antibodies: Recognition of phospholipid-binding protein complexes
    Rauch, J
    [J]. LUPUS, 1998, 7 : S29 - S31
  • [87] Baseline characteristics of participants in the women's health study
    Rexrode, KM
    Lee, IM
    Cook, NR
    Hennekens, CH
    Buring, JE
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 (01): : 19 - 27
  • [88] MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN
    RIDKER, PM
    HENNEKENS, CH
    LINDPAINTER, K
    STAMPFER, MJ
    EISENBERG, PR
    MILETICH, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) : 912 - 917
  • [89] Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
    Ridker, PM
    Hennekens, CH
    Lindpaintner, K
    Stampfer, MJ
    Miletich, JP
    [J]. CIRCULATION, 1997, 95 (01) : 59 - 62
  • [90] Clinical application of C-reactive protein for cardiovascular disease detection and prevention
    Ridker, PM
    [J]. CIRCULATION, 2003, 107 (03) : 363 - 369